Register or Sign in to Save this opportunity, or Send an Inquiry.
Development of Sphingosine Kinase 1 Inhibitors for Treatment of Cancer
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
A drug discovery programme to develop SK-1 inhibitors to prevent chemotherapeutic resistance in cancer
Send an Inquiry


Cancer is one of the biggest killers world wide and it’s prevalence  is only set to increase due to the aging population and changes in lifestyle.

The major problem, in terms of successful treatment of cancer, is the development of chemotherapeutic resistance by the cancer cells  which results in unopposed metastasis of the cancer and ultimately death of the patient. There is a need to identify the mechanisms responsible for the induction of chemotherapeutic resistance in the cancer cell, and develop therapeutics that can prevent resistance, thereby providing an effective means of killing cancer cells.

Researchers at Strathclyde have found that sphingosine kinase-1 (SK1) is present in high levels in the tumours of breast cancer patients. It has also been found to induce resistance in breast and androgen-independent prostate cancer cells. Both indicate that the enzyme may have a role in the generic development of resistance in cancer cells.



Our team have synthesised inhibitors of SK1 and have also identified natural product inhibitors of the enzyme. Additional work is being done to map the allosteric sites of SK1 to inform the ongoing drug discovery programme.  SK1 inhibitors also induce apoptosis of cancer cells, thereby providing an effective means to killing these cells.

Key Benefits

·         Prevent chemotherapeutic resistance of cancer cells

·         Induce apoptosis of cancer cells

Markets and Applications

Applicable to the oncology market which was valued at $44 billion in 2010. Worldwide 2 million women are affected by breast cancer with approximately 0.25 million men being diagnosed with prostate and testicular cancer per year.

Type of Business Relationship Sought

Contact is welcomed from organisations interested in accelerating the development of this programme

Last Updated Oct 2013
Technology Type
Phase of Development EARLY STAGE

Opportunity Contact

Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833